COMMUNIQUÉS West-GlobeNewswire

Guidelight Health Opens Eighth Massachusetts Location, Expanding Access to Structured Mental Health Care
22/07/2026
New Andover location and statewide virtual IOP extend timely, evidence-based care across the Commonwealth ANDOVER, Mass., July 22, 2026 (GLOBE NEWSWIRE) -- Guidelight Health, a leader in evidence-based mental health [...]
Veraify Launches Groundbreaking AI-Native Security Platform Built for the AI Workforce Era
22/07/2026
New Platform Puts Enterprises in the AI Drivers Seat, with More Control over Shadow AI, AI Workforce, and Sensitive Data Movement, Securing AI Adoption Without Slowing Innovation SUNNYVALE, Calif., July 22, 2026 (GLOBE [...]
Bluesight and Pfizer Partner to Provide Source-Tagged RFID Medications to Hospital Pharmacies
22/07/2026
ALEXANDRIA, Va., July 22, 2026 (GLOBE NEWSWIRE) -- Pfizer’s SmartDose medications arrive pre-tagged and pre-associated for use with KitCheck, reducing manual tagging labor as part of RFID inventory management workflows [...]
Cannara annonce une offre publique de rachat dans le cours normal des activités
22/07/2026
MONTRÉAL, 22 juill. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous ») ( TSX : LOVE ) ( OTCQX : LOVFF ) ( FRA : 8CB0 ), producteur verticalement intégré de cannabis de qualité [...]
VisiRose Selected to Present RB-PDAT at ESCRS iNovation® Day 2026 Emerging Company Showcase
22/07/2026
KNOXVILLE, Tenn., July 22, 2026 (GLOBE NEWSWIRE) -- VisiRose, Inc. (“VisiRose” or the “Company”), the clinical-stage ophthalmology subsidiary of Provectus Biopharmaceuticals, Inc. (“Provectus”) (OTCQB: PVCT), a clinical [...]
OKYO Pharma Announces Purchase of Shares by Chief Medical Officer
22/07/2026
LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
Exubrion Therapeutics Promotes Gregory Taglialatela to Chief Commercial Officer
22/07/2026
ATLANTA, July 22, 2026 (GLOBE NEWSWIRE) -- Exubrion Therapeutics ® , the company behind Synovetin OA ® , has promoted Gregory Taglialatela, MBA, to Chief Commercial Officer, effective July 1, 2026. In his new role, [...]
Traferox Technologies Receives FDA Premarket Approval for the TorEx Lung Perfusion System
22/07/2026
MISSISSAUGA, Ontario, July 22, 2026 (GLOBE NEWSWIRE) -- Traferox Technologies, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the TorEx ® Lung Perfusion [...]
Lungpacer Announces New Category III CPT® Codes for AeroPace® Diaphragm Neurostimulation Therapy
22/07/2026
New AMA Category III codes, effective July 1, 2026, support the development of future reimbursement pathways for temporary transvenous diaphragm neurostimulation EXTON, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- Lungpacer [...]
CMR Surgical and NVIDIA showcase future of intelligent surgery with Versius Plus™ at SRS 2026
22/07/2026
CMR Surgical will demonstrate at SRS 2026, for the first time to a surgical audience, the potential for Versius Plus™ to leverage surgical data to help predict how a procedure may unfold. Built on NVIDIA Isaac for [...]
Cannara Announces Normal Course Issuer Bid
22/07/2026
MONTREAL, July 22, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, the “ Company ”, “ us ” or “ we ”) ( TSX: LOVE ) ( OTCQX: LOVFF ) ( FRA: 8CB0 ),a vertically integrated producer of premium-grade cannabis [...]
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
22/07/2026
BOSTON, July 22, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
KC BioHub Awarded $38.1 Million to Advance Regional Biomanufacturing Growth
22/07/2026
Federally recognized Tech Hub positioned to unlock a total of $150 million in federal investment KANSAS CITY, Mo., July 22, 2026 (GLOBE NEWSWIRE) -- The KC BioHub, a program of BioNexus KC , with partners MRIGlobal and [...]
Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors
22/07/2026
MINNEAPOLIS, July 22, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA [...]
Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology
22/07/2026
- Strategic collaboration and equity investment will combine Trinity Biotech's AI-native CGM+ wearable biosensor platform with Latch Medical's innovative intradermal drug delivery technology to develop next-generation [...]
Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases
22/07/2026
RAD101 PET demonstrated 93% concordance with MRI across all evaluable lesions, meeting the trial's primary endpoint. 14 patients with available data from six-month follow-up and biopsy show preliminary 86% (12/14) [...]
Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy
22/07/2026
First RECIST-confirmed durable Partial Response at current highest dose level #3 (90mCi) with the patient remaining progression free beyond seven months Second patient dosed remains progression free on treatment with [...]
BridgeBio Announces FDA Acceptance of NDA for Encaleret for ADH1
22/07/2026
- PDUFA target action date of May 8, 2027 - If approved, encaleret will be the first and only approved therapy specifically indicated for individuals living with ADH1 , representing a potential blockbuster opportunity [...]
Unnatural Products Appoints Finance Leader Neera Ravindran, M.D., M.B.A., as Chief Financial Officer
22/07/2026
SANTA CRUZ, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech developing orally-delivered macrocyclic peptides to address previously undruggable targets, today announced the appointment [...]

Pages